相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Changes in the solubility and phosphorylation of α-synuclein over the course of Parkinson's disease
Jinxia Zhou et al.
ACTA NEUROPATHOLOGICA (2011)
DJ-1 Cleavage by Matrix Metalloproteinase 3 Mediates Oxidative Stress-Induced Dopaminergic Cell Death
Dong-Hee Choi et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Role of Matrix Metalloproteinase 3-mediated α-Synuclein Cleavage in Dopaminergic Cell Death
Dong-Hee Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
被撤回的出版物: Effect of Ser-129 Phosphorylation on Interaction of α-Synuclein with Synaptic and Cellular Membranes (Retracted article. See vol. 295, pg. 13695, 2020)
Naomi P. Visanji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Conserved C-Terminal Charge Exerts a Profound Influence on the Aggregation Rate of α-Synuclein
Katerina Levitan et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
C-terminal part of α-synuclein mediates its activity in promoting proliferation of dopaminergic cells
Juanjuan Yin et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Characterization of Kinases Involved in the Phosphorylation of Aggregated α-Synuclein
Elisa A. Waxman et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2011)
Etiology and Pathogenesis of Parkinson's Disease
Anthony H. Schapira et al.
MOVEMENT DISORDERS (2011)
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
Tim Bartels et al.
NATURE (2011)
Familial Parkinson disease mutations influence α-synuclein assembly
Kenjiro Ono et al.
NEUROBIOLOGY OF DISEASE (2011)
The effect of SNCA 3' region on the levels of SNCA-112 splicing variant
Jeanette J. McCarthy et al.
NEUROGENETICS (2011)
Over-expression of α-synuclein 98 triggers intracellular oxidative stress and enhances susceptibility to rotenone
Kai-Li Ma et al.
NEUROSCIENCE LETTERS (2011)
Ubiquitinylation of α-Synuclein by Carboxyl Terminus Hsp70-Interacting Protein (CHIP) Is Regulated by Bcl-2-Associated Athanogene 5 (BAG5)
Lorraine V. Kalia et al.
PLOS ONE (2011)
A soluble α-synuclein construct forms a dynamic tetramer
Wei Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A novel molecular mechanism for nitrated α-synuclein-induced cell death
Yanying Liu et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2011)
Proteinase K-resistant α-synuclein is deposited in presynapses in human Lewy body disease and A53T α-synuclein transgenic mice
Kunikazu Tanji et al.
ACTA NEUROPATHOLOGICA (2010)
The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia
Walter J. Schulz-Schaeffer
ACTA NEUROPATHOLOGICA (2010)
Differential Phospholipid Binding of α-Synuclein Variants Implicated in Parkinson's Disease Revealed by Solution NMR Spectroscopy
Christina R. Bodner et al.
BIOCHEMISTRY (2010)
Methionine oxidation stabilizes non-toxic oligomers of α-synuclein through strengthening the auto-inhibitory intra-molecular long-range interactions
Wenbo Zhou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
The decrease of β-synuclein in cortical brain areas defines a molecular subgroup of dementia with Lewy bodies
Katrin Beyer et al.
BRAIN (2010)
Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology
Ayse Ulusoy et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
Oxidants induce alternative splicing of α-synuclein: Implications for Parkinson's disease
Shasi V. Kalivendi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Parkinson's disease: insights from pathways
Mark R. Cookson et al.
HUMAN MOLECULAR GENETICS (2010)
Mitochondrial Dysfunction in Parkinson's Disease
Jianhui Zhu et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Accelerated formation of α-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations
Karen A. Lewis et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2010)
Phosphorylation of Synucleins by Members of the Polo-like Kinase Family
Martial K. Mbefo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Phosphorylation at S87 Is Enhanced in Synucleinopathies, Inhibits α-Synuclein Oligomerization, and Influences Synuclein-Membrane Interactions
Katerina E. Paleologou et al.
JOURNAL OF NEUROSCIENCE (2010)
Nitrated α-Synuclein Induces the Loss of Dopaminergic Neurons in the Substantia Nigra of Rats
Zhongwang Yu et al.
PLOS ONE (2010)
Mechanisms of mono- and poly-ubiquitination: Ubiquitination specificity depends on compatibility between the E2 catalytic core and amino acid residues proximal to the lysine
Martin Sadowski et al.
CELL DIVISION (2010)
Preferentially Increased Nitration of α-Synuclein at Tyrosine-39 in a Cellular Oxidative Model of Parkinson's Disease
Steven R. Danielson et al.
ANALYTICAL CHEMISTRY (2009)
A critical evaluation of current staging of α-synuclein pathology in Lewy body disorders
Kurt A. Jellinger
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Formation of dopamine-mediated α-synuclein-soluble oligomers requires methionine oxidation
Su Ling Leong et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
The mitochondrial kinase PINK1, stress response and Parkinson's disease
Marina Jendrach et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2009)
Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System
Kelly J. Inglis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Tonicity-dependent induction of Sgk1 expression has a potential role in dehydration-induced natriuresis in rodents
Songcang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Charge neutralization and collapse of the C-terminal tail of alpha-synuclein at low pH
Sebastian McClendon et al.
PROTEIN SCIENCE (2009)
Structural characterization of α-synuclein in an aggregation prone state
Min-Kyu Cho et al.
PROTEIN SCIENCE (2009)
A critical reappraisal of current staging of Lewy-related pathology in human brain
Kurt A. Jellinger
ACTA NEUROPATHOLOGICA (2008)
Cathepsin D is the main lysosomal enzyme involved in the degradation of α-synuclein and generation of its carboxy-terminally truncated species
Daniel Sevlever et al.
BIOCHEMISTRY (2008)
CHIP targets toxic α-synuclein oligomers for degradation
Julie E. Tetzlaff et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells
D. H. Choi et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Neuroinflammation and oxidation/nitration of α-synuclein linked to dopaminergic neurodegeneration
Hui-Ming Gao et al.
JOURNAL OF NEUROSCIENCE (2008)
Localization of CKII β subunits in Lewy bodies of Parkinson's disease
Myung Yi Ryu et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Differential expression of alpha-synuclein, parkin, and synphilin-1 isoforms in Lewy body disease
Katrin Beyer et al.
NEUROGENETICS (2008)
Cleavage of normal and pathological forms of α-synuclein by neurosin in vitro
Takashi Kasai et al.
NEUROSCIENCE LETTERS (2008)
Nitrated α-Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
Eric J. Benner et al.
PLOS ONE (2008)
Inhibition of α-Synuclein Fibrillization by Dopamine Is Mediated by Interactions with Five C-Terminal Residues and with E83 in the NAC Region
Fernando E. Herrera et al.
PLOS ONE (2008)
Monoubiquitylation of α-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells
Ruth Rott et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Identification and characterization of a new alpha-synuclein isoform and its role in Lewy body diseases
Katrin Beyer et al.
NEUROGENETICS (2008)
Oxidative stress-induced phosphorylation, degradation and aggregation of α-synuclein are linked to upregulated CK2 and cathepsin D
Makio Takahashi et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Dementia with Lewy bodies
Tanis J. Ferman et al.
NEUROLOGIC CLINICS (2007)
Complement activation by islet amyloid polypeptide (IAPP) and α-synuclein 112
Andis Klegeris et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
A variable poly-T sequence modulates α-synuclein isoform expression and is associated with aging
Katrin Beyer et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Calpain-cleavage of α-synuclein -: Connecting proteolytic processing to disease-linked aggregation
Brian M. Dufty et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Presynaptic α-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies
Michael L. Kramer et al.
JOURNAL OF NEUROSCIENCE (2007)
A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation
Yoon Seong Kim et al.
FASEB JOURNAL (2007)
Dyrk1A phosphorylates α-synuclein and enhances intracellular inclusion formation
Eun Joo Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study
David A. Loeffler et al.
JOURNAL OF NEUROINFLAMMATION (2006)
Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease
John P. Anderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease
Shigeki Arawaka et al.
JOURNAL OF NEUROSCIENCE (2006)
Structure and topology of the non-amyloid-β component fragment of human α-synuclein bound to micelles:: Implications for the aggregation process
Marco Bisaglia et al.
PROTEIN SCIENCE (2006)
Elucidation of the substrate binding site of Siah ubiquitin ligase
CM House et al.
STRUCTURE (2006)
Lewy bodies
CW Shults
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Comparison of structure and dynamics of micelle-bound human α-synuclein and Parkinson disease variants
TS Ulmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Diagnosis and management of dementia with Lewy bodies - Third report of the DLB consortium
IG McKeith et al.
NEUROLOGY (2005)
Molecular-level secondary structure, polymorphism, and dynamics of full-length α-synuclein fibrils studied by solid-state NMR
H Heise et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates α-synuclein degradation decisions between proteasomal and lysosomal pathways
YG Shin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A precipitating role for truncated α-synuclein and the proteasome in α-synuclein aggregation -: Implications for pathogenesis of Parkinson disease
CW Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cleavage of α-synuclein by calpain:: Potential role in degradation of fibrillized and nitrated species of α-synuclein
AJ Mishizen-Eberz et al.
BIOCHEMISTRY (2005)
α-Synuclein phosphorylation controls neurotoxicity and inclusion formation in a Drosophila model of Parkinson disease
L Chen et al.
NATURE NEUROSCIENCE (2005)
Multiple regions of α-synuclein are associated with Parkinson's disease
JC Mueller et al.
ANNALS OF NEUROLOGY (2005)
Structure and dynamics of micelle-bound human α-synuclein
TS Ulmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The E46K mutation in α-synuclein increases amyloid fibril formation
EA Greenbaum et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Aggregation promoting C-terminal truncation of α-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations
WX Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Ubiquitination of α-synuclein
T Nonaka et al.
BIOCHEMISTRY (2005)
Function and regulation of Cullin-RING ubiquitin ligases
MD Petroski et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Ubiquitylation of synphilin-1 and α-synuclein by SIAH and its presence in cellular inclusions and Lewy bodies imply a role in Parkinson's disease
E Liani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia
JJ Zarranz et al.
ANNALS OF NEUROLOGY (2004)
Impaired degradation of mutant α-synuclein by chaperone-mediated autophagy
AM Cuervo et al.
SCIENCE (2004)
BAG5 inhibits parkin and enhances dopaminergic neuron degeneration
SK Kalia et al.
NEURON (2004)
Differential expression of α-synuclein isoforms in dementia with Lewy bodies
K Beyer et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2004)
Structure of membrane-bound α-synuclein studied by site-directed spin labeling
CC Jao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
α-synuclein promoter confers susceptibility to Parkinson's disease
P Pals et al.
ANNALS OF NEUROLOGY (2004)
Inflammation and neurodegeneration in Parkinson's disease
PL McGeer et al.
PARKINSONISM & RELATED DISORDERS (2004)
Ubiquitination of α-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function
GK Tofaris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies
A Iwata et al.
HUMAN MOLECULAR GENETICS (2003)
Structural organization of α-synuclein fibrils studied by site-directed spin labeling
A Der-Sarkissian et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Distinct cleavage patterns of normal and pathologic forms of α-synuclein by calpain I in vitro
AJ Mishizen-Eberz et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Role of α-synuclein carboxy-terminus on fibril formation in vitro
IVJ Murray et al.
BIOCHEMISTRY (2003)
α-synuclein is degraded by both autophagy and the proteasome
JL Webb et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Accumulation of phosphorylated α-synuclein in aging human brain
Y Saito et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Context of multiubiquitin chain attachment influences the rate of Sic1 degradation
MD Petroski et al.
MOLECULAR CELL (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Phosphorylation of α-synuclein characteristic of synucleinopathy lesions is recapitulated in α-synuclein transgenic Drosophila
M Takahashi et al.
NEUROSCIENCE LETTERS (2003)
Endoproteolytic activity of the proteasome
CW Liu et al.
SCIENCE (2003)
Neuropathological spectrum of synucleinopathies
KA Jellinger
MOVEMENT DISORDERS (2003)
Phosphorylated α-synuclein is ubiquitinated in α-synucleinopathy lesions
M Hasegawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Microscopic analysis of polymerization dynamics with individual actin filaments
I Fujiwara et al.
NATURE CELL BIOLOGY (2002)
Amino acid determinants of α-synuclein aggregation:: putting together pieces of the puzzle
VN Uversky et al.
FEBS LETTERS (2002)
Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53→Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice
MK Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein
BI Giasson et al.
NEURON (2002)
Biophysical properties of the synucleins and their propensities to fibrillate -: Inhibition of α-synuclein assembly by β- and γ-synucleins
VN Uversky et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Regulation of synaptophysin degradation by mammalian homologues of Seven in Absentia
TC Wheeler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease
BCV Campbell et al.
JOURNAL OF NEUROCHEMISTRY (2001)
CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein
S Murata et al.
EMBO REPORTS (2001)
α-Synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome
GK Tofaris et al.
FEBS LETTERS (2001)
Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins
RJ Perrin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling
J Demand et al.
CURRENT BIOLOGY (2001)
Parkin ubiquitinates the α-synuclein-interacting protein, synphilin-1:: implications for Lewy-body formation in Parkinson disease
KKK Chung et al.
NATURE MEDICINE (2001)
Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human α-synuclein
J Li et al.
BIOCHEMISTRY (2001)
Ubiquitination of a new form of α-synuclein by parkin from human brain:: Implications for Parkinson's disease
H Shimura et al.
SCIENCE (2001)
α-Synuclein is phosphorylated by members of the Src family of protein-tyrosine kinases
CE Ellis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Activated Fyn phosphorylates α-synuclein at tyrosine residue 125
T Nakamura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
A hydrophobic stretch of 12 amino acid residues in the middle of α-synuclein is essential for filament assembly
BI Giasson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions
BI Giasson et al.
SCIENCE (2000)
Synucleins are a novel class of substrates for G protein-coupled receptor kinases
AN Pronin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation
LC Serpell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Constitutive phosphorylation of the Parkinson's disease associated α-synuclein
M Okochi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
